Industry Verticals »

All Categories

Insights »

About TMR »

HIV/AIDS Immunoassay Diagnostics Market

HIV/AIDS Immunoassay Diagnostics Market (Product: Analyzers and Kits & Reagents; Technology: Enzyme-linked Immunosorbent Assay [ELISA], Chemiluminescence Immunoassay [CLIA], and Others [Immunofluorescent Assay {IFA}, Radioimmunoassay {RIA}, and Enzyme-linked Fluorescent Assay {ELFA}]; and End User: Hospitals, Diagnostic Laboratories, Blood Banks, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Progress in Diagnostic Technology Expected to Improve HIV/AIDS Detection

Diagnostic technology has evolved at a rapid pace over the past decade, owing to significant breakthroughs in research and development. Within the HIV/AIDS immunoassay diagnostics market landscape, the demand for automated clinical laboratory has paved the way for efficient and reliable antibodies and antigen identification techniques. Despite significant progress, the human immunodeficiency virus (HIV) continues to be a major global health problem and a medical challenge. Some of the most effective and critical HIV management strategies include antiretroviral therapy (ART) initiation, early diagnosis, and assessment of the viral load.

HIV diagnostic tests offer two solutions - detection of virus molecules (p24 antigen and HIV RNA) and/or different antibodies to the virus. HIV/AIDS immunoassays, in particular, are used to detect antibodies and p24 antigen. Due to the growing need to curb HIV/AIDS and other types of HIV infections, the demand for efficient diagnostic techniques has increased significantly worldwide. The global HIV/AIDS immunoassay diagnostics market is expected to expand from ~US$ 570 Mn in 2019 to a value of ~US$ 870 Mn by 2027.

global hiv aids diagnostics market infographic

Growing Focus on Improving Effectiveness of HIV Diagnostics – A Rising Trend

Around 38 million individuals across the world had HIV in 2018 of which, approximately 36 million were adults. Furthermore, ~1.7 million new HIV cases were registered in 2018 and the numbers continue to grow, especially in the sub-Saharan region and low-income economies. Key participants involved in the HIV/AIDS immunoassay diagnostics market are focusing on simplifying and improving the effectiveness of HIV diagnostics.

Antibody screening tests including the enzyme linked immunosorbent assay (ELISA) are predominantly used to measure antibodies in blood. This test is generally the first test ordered by healthcare professionals to detect HIV antigens in the blood. Traditionally, enzyme-linked immunosorbent assays are complex, expensive, and often require a skilled professional. However, as ELISA is easier and safer than radioimmunoassay (RIA); its adoption will continue to grow at a steady pace over the forecast period (2019-2027). Thus, the ELISA segment is projected to create an incremental opportunity of ~US$ 112 Mn between the stipulated timeframe of the study. The diagnostic results using ELISA could take a few days, which has led to the need for rapid testing techniques.

Despite steady growth of the ELISA segment, the chemiluminescent immunoassay segment (CLIA) segment is expected to hold a larger share of the HIV/AIDS immunoassay diagnostics market, in terms of value. By the end of 2027, the CLIA segment is likely to account for ~48% of the total share of the HIV/AIDS immunoassay diagnostics market and witness a CAGR of ~6% during the forecast period. Over the past few years, CLIA has gained significant popularity in various sectors, including clinical diagnosis, life sciences, pharmaceutical analysis, and environmental monitoring, among others due to factors such as optimum specificity, easy-to-use equipment, wider linear range, and high sensitivity. Techniques based on chemiluminescent are increasingly being used for clinical analysis and several biomedical research activities.

Market Players to Focus on Efficiency and Expanding Product Portfolio

Presently, major players operating in the global HIV/AIDS immunoassay diagnostics market are striving to offer effective, reliable, cost-effective HIV/AIDS immunoassay diagnostics. In addition, increasing prevalence of HIV/AIDS and HIV infections worldwide have prompted market participants to provide new and improved HIV testing technologies. Companies are focusing on improving patient outcomes and minimizing disease transmission, which requires reliable and accurate clinical laboratory testing. For instance, Siemens Healthineers launched the Atellica ® IM and ADVIA Centaur ® HIV Combo to improve the detection of HIV infections. The entry of new technologies, including the third-generation enzyme immunoassay, which detects IgM and IgG antibodies and fourth-generation enzyme immunoassay that detect HIV p24 and HIV antibodies, are some of the most recent groundbreaking developments in the global HIV/AIDS immunoassay market. 

Moreover, product development is likely to fuel the global HIV/AIDS immunoassay market, as companies are seeking approvals from the U.S. FDA. For instance, Shenzen New Industries Biomedical Engineering Co., Ltd (SNIBE) became the first China-based company in the HIV/AIDS immunoassay diagnostics market to receive the approval from the U.S. FDA for the newly developed automated immunoassay analyzer.

global hiv aids diagnostics market segmentation

Analysts’ Viewpoint

Companies operating in the HIV/AIDS immunoassay diagnostics market should focus on improving the effectiveness of their HIV diagnosis techniques. In addition, clinical and laboratory trials of newer technologies will play an imperative role in driving the growth of the HIV/AIDS immunoassay diagnostics market. Despite a healthy competition from the ELISA segment, CLIA is likely to retain its dominance, in terms of adoption, during the forecast period. Developments in the CLIA technology, including the flow-injection CLIA technology, will address problems associated with existing alternatives.

Global HIV/AIDS Immunoassay Diagnostics Market: Overview

  • This report analyzes the current scenario and future prospects of the global HIV/AIDS immunoassay diagnostics market. Rise in prevalence of sexually transmitted diseases, HIV infected population, and development of new treatment modes are key factors projected to drive the global HIV/AIDS immunoassay diagnostics market during the forecast period.
  • The report provides an elaborate executive summary, including a snapshot of various segments of the HIV/AIDS immunoassay diagnostics market. It also provides elaborate information and data analysis of the global HIV/AIDS immunoassay diagnostics market with regard to segments based on technology, product, end user, and region.
  • The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that impact the global HIV/AIDS immunoassay diagnostics market
  • The report also includes company profiles, which provide information about their business, product portfolios, and competitive landscape in the HIV/AIDS immunoassay diagnostics market
  • The report on the global HIV/AIDS immunoassay diagnostics market offers market attractiveness analysis of regions and segments
  • The last section of the report comprises quantitative and qualitative analysis on market share/position of key players operating in the global HIV/AIDS immunoassay diagnostics market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global HIV/AIDS immunoassay diagnostics market. 

Global HIV/AIDS Immunoassay Diagnostics Market: Key Segments

  • In terms of product, the global HIV/AIDS immunoassay diagnostics market has been classified into analyzers and kits & reagents. The kits & reagents segment held a major share of the global HIV/AIDS immunoassay diagnostics market in 2018 and the trend is anticipated to continue during the forecast period.
  • Based on technology, the global HIV/AIDS immunoassay diagnostics market has been segmented into enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and others (immunofluorescent assay (IFA), radioimmunoassay (RIA), and enzyme-linked fluorescent assay (ELFA)). The chemiluminescence immunoassay (CLIA) segment accounted for a majority of the market share in 2018.
  • In terms of end user, the global HIV/AIDS immunoassay diagnostics market has been categorized into hospitals, diagnostic laboratories, blood banks, and others
  • The market value and forecast for each of these segments have been provided from 2017 to 2027. The CAGRs of respective segments have also been provided from 2019 to 2027, considering 2018 as the base year. 

Global HIV/AIDS Immunoassay Diagnostics Market: Regional Outlook

  • In terms of region, the global HIV/AIDS immunoassay diagnostics market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
  • The HIV/AIDS immunoassay diagnostics market report provides value and forecast for each region and country/sub-region from 2017 to 2027. The CAGRs for each of these regions and countries have also been provided for the forecast period from 2019 to 2027. The HIV/AIDS immunoassay diagnostics market study also covers the competitive scenario in these regions. 

Companies Mentioned in Report

  • Key players in the global HIV/AIDS immunoassay diagnostics market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the global HIV/AIDS immunoassay diagnostics market report are
    • F. Hoffmann-La Roche Ltd
    • Bio-Rad Laboratories, Inc.
    • Siemens Healthineers AG
    • DiaSorin S.p.A.
    • Abbott Laboratories
    • Ortho Clinical Diagnostics (a part of Carlyle Group)
    • Shenzhen New Industries Biomedical Engineering Co., Ltd.
    • bioMérieux SA
    • Fujirebio (Miraca Group) 

Frequently Asked Questions

What is the total market worth of HIV/AIDS immunoassay diagnostics market?

HIV/AIDS immunoassay diagnostics market to reach a valuation of ~US$ 870 Mn by 2027

What is the anticipated CAGR of the HIV/AIDS immunoassay diagnostics market in the forecast period?

HIV/AIDS immunoassay diagnostics market is projected to expand at a CAGR of ~5% from 2019 to 2027

What are the key driving factors for the growth of the HIV/AIDS immunoassay diagnostics market?

HIV/AIDS immunoassay diagnostics market is driven by rise in prevalence of sexually transmitted diseases and HIV infected population

Which is the rising prominent segment in the HIV/AIDS immunoassay diagnostics market?

The kits & reagents segment held a major share of the global HIV/AIDS immunoassay diagnostics market and the trend is anticipated to continue during the forecast period

Who are the key players in the global HIV/AIDS immunoassay diagnostics market?

Key players in the global HIV/AIDS immunoassay diagnostics market include F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Siemens Healthineers AG, DiaSorin S.p.A., Abbott Laboratories

1. Preface 

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global HIV/AIDS Immunoassay Diagnostics Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

    5.1. Technological Advancements

    5.2. Key Industry Developments

    5.3. Epidemiology Analysis

    5.4. Number of HIV/AIDS Immunoassay Diagnostics Tests, by Region

    5.5. Pricing Analysis

6. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Product 

    6.1. Introduction & Definition 

    6.2. Global HIV/AIDS Immunoassay Diagnostics Market Value Forecast, by Product, 2017–2027

        6.2.1. Analyzers

        6.2.2. Kits & Reagents

    6.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product

7. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Technology

    7.1. Introduction 

    7.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

        7.2.1.  ELISA

        7.2.2. CLIA

        7.2.3. Others

    7.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology

8. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by End User 

    8.1. Introduction 

    8.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

        8.2.1. Hospitals

        8.2.2. Diagnostic Laboratories

        8.2.3. Blood Banks

        8.2.4. Others

    8.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User

9. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Region

    9.1. Introduction 

    9.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2027

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa  

    9.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Region

10. North America HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast 

    10.1. Introduction

    10.2. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

        10.2.1. Analyzers

        10.2.2. Kits & Reagents

    10.3. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

        10.3.1. ELISA

        10.3.2. CLIA

        10.3.3. Others

    10.4. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

        10.4.1. Hospitals

        10.4.2. Diagnostic Laboratories

        10.4.3. Blood Banks

        10.4.4. Others

    10.5. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Technology

        10.6.3. By End User 

        10.6.4. By Country

11. Europe HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast 

    11.1. Introduction

    11.2. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

        11.2.1. Analyzers

        11.2.2. Kits & Reagents

    11.3. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

        11.3.1. ELISA

        11.3.2. CLIA

        11.3.3. Others

    11.4. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

        11.4.1. Hospitals

        11.4.2. Diagnostic Laboratories

        11.4.3. Blood Banks

        11.4.4. Others

    11.5. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy 

        11.5.6. Russia

        11.5.7. Rest of Europe

    11.6. Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Technology 

        11.6.3. By End User

        11.6.4. By Country/Sub-region

12. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast 

    12.1. Introduction

    12.2. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

        12.2.1. Analyzers

        12.2.2. Kits & Reagents

    12.3. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

        12.3.1. ELISA

        12.3.2. CLIA

        12.3.3. Others

    12.4. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

        12.4.1. Hospitals

        12.4.2. Diagnostic Laboratories

        12.4.3. Blood Banks

        12.4.4. Others

    12.5. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        12.5.1. Japan

        12.5.2. China

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Technology

        12.6.3. By End User  

        12.6.4. By Country/Sub-region

13. Latin America  HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast 

    13.1. Introduction

    13.2. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

        13.2.1. Analyzers

        13.2.2. Kits & Reagents

    13.3. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

        13.3.1. ELISA

        13.3.2. CLIA

        13.3.3. Others

    13.4. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

        13.4.1. Hospitals

        13.4.2. Diagnostic Laboratories

        13.4.3. Blood Banks

        13.4.4. Others

    13.5. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Technology

        13.6.3. By End User 

        13.6.4. By Country/Sub-region

14. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast 

    14.1. Introduction

    14.2. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

        14.2.1. Analyzers

        14.2.2. Kits & Reagents

    14.3. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

        14.3.1. ELISA

        14.3.2. CLIA

        14.3.3. Others

    14.4. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

        14.4.1. Hospitals

        14.4.2. Diagnostic Laboratories

        14.4.3. Blood Banks

        14.4.4. Others

    14.5. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

        14.6.1. By Product

        14.6.2. By Technology

        14.6.3. By End User 

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (By Tier and Size of companies)

    15.2. Global HIV/AIDS Immunoassay Diagnostics Market Share Analysis, by Company (2018)

    15.3. Company Profiles

        15.3.1. F. Hoffmann-La Roche Ltd.

            15.3.1.1. Company Description

            15.3.1.2. Business Overview

            15.3.1.3. Financial Overview

            15.3.1.4. Strategic Overview

            15.3.1.5. SWOT Analysis

        15.3.2. Bio-Rad Laboratories, Inc.

            15.3.2.1. Company Description

            15.3.2.2. Business Overview

            15.3.2.3. Financial Overview

            15.3.2.4. Strategic Overview

            15.3.2.5. SWOT Analysis

        15.3.3. Siemens Healthineers AG. 

            15.3.3.1. Company Description

            15.3.3.2. Business Overview

            15.3.3.3. Financial Overview

            15.3.3.4. Strategic Overview

            15.3.3.5. SWOT Analysis

        15.3.4. DiaSorin S.p.A.

            15.3.4.1. Company Description

            15.3.4.2. Business Overview

            15.3.4.3. Financial Overview

            15.3.4.4. Strategic Overview

            15.3.4.5. SWOT Analysis

        15.3.5. Abbott Laboratories

            15.3.5.1. Company Description

            15.3.5.2. Business Overview

            15.3.5.3. Financial Overview

            15.3.5.4. Strategic Overview

            15.3.5.5. SWOT Analysis

        15.3.6. Ortho Clinical Diagnostics (a part of Carlyle Group)

            15.3.6.1. Company Description

            15.3.6.2. Business Overview

            15.3.6.3. Financial Overview

            15.3.6.4. Strategic Overview

            15.3.6.5. SWOT Analysis

        15.3.7. Shenzhen New Industries Biomedical Engineering Co., Ltd.

            15.3.7.1. Company Description

            15.3.7.2. Business Overview

            15.3.7.3. Financial Overview

            15.3.7.4. Strategic Overview

            15.3.7.5. SWOT Analysis

        15.3.8. bioMérieux SA 

            15.3.8.1. Company Description

            15.3.8.2. Business Overview

            15.3.8.3. Financial Overview

            15.3.8.4. Strategic Overview

            15.3.8.5. SWOT Analysis

        15.3.9. Fujirebio (Miraca Group) 

            15.3.9.1. Company Description

            15.3.9.2. Business Overview

            15.3.9.3. Financial Overview

            15.3.9.4. Strategic Overview

            15.3.9.5. SWOT Analysis

List of Tables

Table 01: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 03: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 04: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 05: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 06: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 07: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 08: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 09: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 10: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 11: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 12: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 13: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 14: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 15: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 16: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 17: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 18: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 19: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 20: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 21: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 22: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 23: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027

Table 24: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027

List of Figures

Figure 01: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2027

Figure 02: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

Figure 03: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018

Figure 04: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018

Figure 05: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018

Figure 06: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Region, 2018

Figure 07: HIV/AIDS Immunoassay Diagnostics Market – Mergers, Acquisitions, Collaborations, Partnerships & New Product Launch 

Figure 08: Technological Advancements

Figure 09: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027

Figure 10: Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 11: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzers, 2017–2027

Figure 12: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Kits & Reagents, 2017–2027

Figure 13: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027

Figure 14: Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019–2027

Figure 15: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by ELISA, 2017–2027

Figure 16: Global Ne HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CLIA, 2017–2027

Figure 17: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 18: Global HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027

Figure 19: Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019–2027

Figure 20: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 21: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2017–2027

Figure 22: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Banks, 2017–2027

Figure 23: Global HIV/AIDS Immunoassay Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 24: Global HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Region, 2018 and 2027

Figure 25: Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Region, 2019–2027

Figure 26: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 27: North America HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country, 2018 and 2027

Figure 28: North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country, 2019–2027

Figure 29: North America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027

Figure 30: North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 31: North America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027

Figure 32: North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019–2027

Figure 33: North America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027

Figure 34: North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019–2027

Figure 35: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 36: Europe HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 37: Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 38: Europe HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027

Figure 39: Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 40: Europe HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027

Figure 41: Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019–2027

Figure 42: Europe HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027

Figure 43: Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019–2027

Figure 44: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 45: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 46: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 47: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027

Figure 48: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 49: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027

Figure 50: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019–2027

Figure 51: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027

Figure 52: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019–2027

Figure 53: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 54: Latin America HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 55: Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 56: Latin America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027

Figure 57: Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 58: Latin America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027

Figure 59: Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019–2027

Figure 60: Latin America HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027

Figure 61: Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019–2027

Figure 62: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 63: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 64: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 65: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Product, 2018 and 2027

Figure 66: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product, 2019–2027

Figure 67: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by Technology, 2018 and 2027

Figure 68: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology, 2019–2027

Figure 69: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value Share (%), by End User, 2018 and 2027

Figure 70: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User, 2019–2027

Figure 71: Global HIV/AIDS Immunoassay Diagnostics Market Share Analysis, by Company, 2018 

Copyright © Transparency Market Research, Inc. All Rights reserved

HIV/AIDS Immunoassay Diagnostics Market

Schedule a Call